Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru

PHASE3CompletedINTERVENTIONAL
Enrollment

1,244

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2014

Conditions
HIVAIDSHIV Infections
Interventions
OTHER

DOT-HAART

For 8 months, DOT-HAART of all doses in the participant's home or alternate location. DOT worker ensures that HIV medications are taken as indicated and witnesses ingestion of all medications including other medications prescribed by physician. The worker will be trained to identify, triage and notify providers of any psychosocial and medical problems/complications. Transition to self-administration begins in months 9-12 when DOT will be tapered and greater participation of treatment supporter to prepare patients for self-administration.

Trial Locations (1)

Unknown

Socios En Salud, Lima

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Partners in Health

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

lead

Brigham and Women's Hospital

OTHER